COLLABORATE TO ACCELERATE
Live / Allowed — Notice of allowance issued (as of 30 Sept 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 13 Dec 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98311999
- Mark type
- Stylized text
- Filed
- 13 Dec 2023
- Published for opposition
- 03 Jun 2025
- Attorney of record
- Abe J. Shanehsaz
Goods and services
- Class 001 — Chemicals: glycolic acid; aspartate; dimeric aspartate, namely, iminodissuccinate, and ethylenediamine-N,N'-disuccinate; polysuccinimide; polyaspartate; polyaspartate polymers; polyaspartate polymeric additives; polyaspartate for use in the manufacture of industrial, consumer, agricultural, and household products; polyaspartate polymers for use in the manufacture of industrial, consumer, agricultural, and household products; polyaspartate polymeric additives for use in the manufacture of industrial, consumer, agricultural, and household products; Chemical substances for industrial use, namely, propanedioic acid, ethyl malonate, mono-methyl malonate, mono-ethyl malonate, mono-propyl malonate, mono-butyl malonate, mono-tert-butyl malonate, di-alkyl malonate esters, namely, dimethyl malonate, diethyl malonate, dipropyl malonate, dibutyl malonate, Meldrum's acid, dialkyl malonate, e-caprolactam, d-valerolactam, dialkylated 1,3-dicarbonyl compounds, namely, diethyl 2,2-dimethylmalonate, diethyl 2,2-diethylmalonate, diethyl 2,2-dipropylmalonate, diethyl 2,2-dibutylmalonate, dimethyl 2,2-dimethylmalonate, dimethyl 2,2-diethylmalonate, dimethyl 2,2-dipropylmalonate, and dimethyl 2,2-dibutylmalonate, lactic acid, pyruvic acid, hydroxypropionic acid, formate, succinic acid, 1,3-propanediol, and 2,3-butanediol, 1,4-butanediol; chemicals, biochemicals, and reagents, namely, recombinant proteins, expression vectors, oligonucleotides, amino acids for laboratory use, reagents for recombinant protein expression purification; chemical preparations and substances for use in the manufacture of chemical substances for industrial use
- Class 042 — Scientific and technological services: Scientific and industrial research in the field of biochemistry; scientific biochemical laboratory services concerning synthesis of recombinant polypeptides and proteins for production of chemical substances for industrial use, namely, propanedioic acid, ethyl malonate, mono-methyl malonate, mono-ethyl malonate, mono-ethyl malonate, mono-propyl malonate, mono-butyl malonate, mono-tert-butyl malonate, and the like, di-alkyl malonate esters, namely, dimethyl malonate, diethyl malonate, dipropyl malonate, dibutyl malonate, and the like, Meldrum's acid, dialkyl malonate, e-caprolactam, d-valerolactam, dialkylated 1,3-dicarbonyl compounds, namely, diethyl 2,2-dimethylmalonate, diethyl 2,2-diethylmalonate, diethyl 2,2-dipropylmalonate, diethyl 2,2-dibutylmalonate, dimethyl 2,2-dimethylmalonate, dimethyl 2,2-diethylmalonate, dimethyl 2,2-dipropylmalonate, and dimethyl 2,2-dibutylmalonate, lactic acid, pyruvic acid, hydroxypropionic acid, formate, succinic acid, 1,3-propanediol, and 2,3-butanediol, 1,4-butanediol
Owner
- Lygos, Inc., Hayward, CA, US
- Lygos, Inc., Berkeley, CA, US
Prosecution history
- 30 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Dec 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Dec 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 30 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Jun 2025 — PUBLISHED FOR OPPOSITION
- 28 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Apr 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Jan 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 07 Jan 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 19 Oct 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Oct 2024 — NON-FINAL ACTION E-MAILED